Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,487 papers from all fields of science
Search
Sign In
Create Free Account
Maxy G34
Known as:
MAXY-G34
, PEG-GCSF MAXY-G34
, Pegylated Granulocyte Colony Stimulating Factor MAXY-G34
A long-acting, pegylated recombinant variant of human granulocyte colony-stimulating factor (G-CSF) with immunomodulating activity. Pegylated…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Granulocyte Colony-Stimulating Factor
Polyethylene Glycols
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Managerial Discretion Over Loan Loss Reserves during the Global Financial Crisis
Glen A. Hansen
2015
Corpus ID: 56359651
I analyze loan loss reserves during the Global Financial Crises in the late 2000s. I develop a regression model that separates…
Expand
Review
2013
Review
2013
The challenge to reposition three divergent higher education institutions as a new comprehensive institution
N. Bresler
2013
Corpus ID: 55123811
This study was designed to assist three higher education institutions that were forced into a merger to develop an identity…
Expand
2010
2010
Performance, Firm Size, and the 'Basicness' of Research
Andrea Patacconi
,
Sharon Belenzon
2010
Corpus ID: 18115303
Using novel firm-level panel data this paper investigates the relationship between performance, firm size, and the composition of…
Expand
Review
2010
Review
2010
The Impact of Foreign Acquisitions on the Investors' R&D Activities - Firm-Level Evidence
Joel Stiebale
2010
Corpus ID: 14304559
This paper provides empirical evidence on the relationship between cross-border acquisitions and innovation activities at the…
Expand
2010
2010
The Search for Corporate Control
Marc Martos-Vila
2010
Corpus ID: 14070523
This paper analyzes the market for corporate control and acquisitions by explicitly modeling a typical firm's choice whether to…
Expand
2009
2009
Size, ownership and the market for corporate control
D. Robinson
2009
Corpus ID: 8610814
2009
2009
An open-label, dose-escalating study of Maxy-G34, a novel potent, long-acting Pegylated G-CSF, compared with pegfilgrastim (PF) for the treatment of chemotherapy induced neutropenia (CIN).
L. Schwartzberg
,
S. L. Sankar
,
+7 authors
K. Possinger
Journal of Clinical Oncology
2009
Corpus ID: 9037000
e14500 Background: rhG-CSF reduces the incidence and duration of CIN in patients (pts) receiving myelosuppressive chemotherapy…
Expand
2008
2008
Advances in Accounting, incorporating Advances in International Accounting
John Q. Li
,
Yuan Ding
2008
Corpus ID: 55082394
The United States and Fra nce are both most developed economies in the world. Their socio-economic institutions, however, are…
Expand
2003
2003
Who Makes Acquisitions ? CEO Overcon dence and the Market s Reaction
Ulrike Malmendier
2003
Corpus ID: 261657583
Overcon dent CEOs over-estimate their ability to generate returns. Thus, on the margin, they undertake mergers that destroy value…
Expand
1975
1975
Relative abundance of big and little gastrins in the tumours and blood of patients with the Zollinger Ellison syndrome.
G. Dockray
,
J. H. Walsh
,
E. Passaro
Gut
1975
Corpus ID: 25073012
The relative concentrations of big gastrin (G-34) and little gastrin (G-17) were compared in the sera and tumours (gastrinomas…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE